Advertisement

Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on cytokine messenger RNA expression following viral challenge in calves

Congrong MiaoDepartment of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Present address is the CDC, Respiratory Viruses Section, 1600 Clifton Rd, Atlanta, GA 30333.

Search for other papers by Congrong Miao in
Current site
Google Scholar
PubMed
Close
 MS
,
Amelia R. WoolumsDepartment of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Amelia R. Woolums in
Current site
Google Scholar
PubMed
Close
 DVM, MVSc, PhD
,
Dante S. ZarlengaBovine Functional Genomics Laboratory, Agricultural Research Services, USDA, Beltsville, MD 20705.

Search for other papers by Dante S. Zarlenga in
Current site
Google Scholar
PubMed
Close
 PhD
,
Corrie C. BrownDepartment of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Corrie C. Brown in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
James C. Brown JrDepartment of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Present address is the Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH 43210.

Search for other papers by James C. Brown Jr in
Current site
Google Scholar
PubMed
Close
 DVM
,
Shamita M. WilliamsDepartment of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Shamita M. Williams in
Current site
Google Scholar
PubMed
Close
 BS
, and
Melissa A. ScottDepartment of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Present address is Southeast Poultry Research Laboratory, USDA, 934 College Station Rd, Athens, GA 30605.

Search for other papers by Melissa A. Scott in
Current site
Google Scholar
PubMed
Close
 MS

Abstract

Objective—To characterize cytokine messenger RNA (mRNA) expression in intranasally vaccinated calves after bovine respiratory syncytial virus (BRSV) challenge.

Animals—Twelve 8- to 12-week-old calves.

Procedures—Calves received modified-live BRSV vaccine (vaccinated) or spent tissue culture medium (mock-vaccinated) intranasally, followed by challenge 30 days later with BRSV, or mock challenge with spent tissue culture medium (mock-challenge controls). Interleukin-4 (IL-4) and interferon-γ (IFN-γ) mRNA was measured in lungs, bronchoalveolar lavage (BAL) fluid cells, pharyngeal tonsils, and tracheobronchial lymph nodes, and tumor necrosis factor-α (TNF-α) mRNA was measured in lungs and BAL fluid cells by reverse transcriptase-competitive polymerase chain reaction assay.

Results—Resistance to clinical signs of disease was conferred in vaccinated calves. Expression of TNF-α mRNA in lungs and BAL fluid cells was higher in mock-vaccinated calves than control or vaccinated calves. In the lung, IL-4 mRNA expression was higher in vaccinated calves than control or mock-vaccinated calves. In pharyngeal tonsils, expression of mRNA for IL-4 and IFN-γ was higher in mock-vaccinated calves than control calves. In tracheobronchial lymph nodes, IFN-γ mRNA expression was higher in mock-vaccinated calves than vaccinated calves.

Conclusions and Clinical Relevance—Although vaccinated calves had decreased clinical signs of disease after BRSV challenge, compared with mock-vaccinated calves, this difference was not related to a T helper type 1 bias, as determined by increased expression of interferon-γ mRNA relative to interleukin-4 mRNA in lungs, BAL fluid cells, or tracheobronchial lymph nodes of vaccinated calves. Pulmonary inflammation was decreased in vaccinated calves as determined by decreased expression of TNF-α mRNA. (Am J Vet Res 2004;65:725–733)

Abstract

Objective—To characterize cytokine messenger RNA (mRNA) expression in intranasally vaccinated calves after bovine respiratory syncytial virus (BRSV) challenge.

Animals—Twelve 8- to 12-week-old calves.

Procedures—Calves received modified-live BRSV vaccine (vaccinated) or spent tissue culture medium (mock-vaccinated) intranasally, followed by challenge 30 days later with BRSV, or mock challenge with spent tissue culture medium (mock-challenge controls). Interleukin-4 (IL-4) and interferon-γ (IFN-γ) mRNA was measured in lungs, bronchoalveolar lavage (BAL) fluid cells, pharyngeal tonsils, and tracheobronchial lymph nodes, and tumor necrosis factor-α (TNF-α) mRNA was measured in lungs and BAL fluid cells by reverse transcriptase-competitive polymerase chain reaction assay.

Results—Resistance to clinical signs of disease was conferred in vaccinated calves. Expression of TNF-α mRNA in lungs and BAL fluid cells was higher in mock-vaccinated calves than control or vaccinated calves. In the lung, IL-4 mRNA expression was higher in vaccinated calves than control or mock-vaccinated calves. In pharyngeal tonsils, expression of mRNA for IL-4 and IFN-γ was higher in mock-vaccinated calves than control calves. In tracheobronchial lymph nodes, IFN-γ mRNA expression was higher in mock-vaccinated calves than vaccinated calves.

Conclusions and Clinical Relevance—Although vaccinated calves had decreased clinical signs of disease after BRSV challenge, compared with mock-vaccinated calves, this difference was not related to a T helper type 1 bias, as determined by increased expression of interferon-γ mRNA relative to interleukin-4 mRNA in lungs, BAL fluid cells, or tracheobronchial lymph nodes of vaccinated calves. Pulmonary inflammation was decreased in vaccinated calves as determined by decreased expression of TNF-α mRNA. (Am J Vet Res 2004;65:725–733)